James E. Levine

Chief Financial Officer, Verenium Corporation.

Companies

KAZIA THERAPEUTICS LTDChief financial officer Jun 15, 2026 to now¹
Cardiff Oncology, Inc.Chief financial officer Jul 12, 2021 to Apr 16, 2026²
Cidara TherapeuticsChief financial officer Dec 4, 2018 to Mar 19, 2021³
Verenium CorporationPresident Aug 2, 2013 to Nov 4, 2013⁴
Verenium CorporationBoard member Aug 16, 2011 to Nov 4, 2013⁵
Verenium CorporationChief executive officer Aug 16, 2011 to Nov 4, 2013⁵
Verenium CorporationChief financial officer May 7, 2009 to Mar 1, 2011⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cardiff Oncology, Inc. CRDF127,716 shares⁷$115.0K at $0.90Dec 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 18, 2024Bought 2,400 shares at $5.00 of Cardiff Oncology, Inc.⁷
Dec 17, 2024Bought 2,752 shares at $5.42 of Cardiff Oncology, Inc.⁷
Dec 16, 2024Bought 2,564 shares at $3.83 of Cardiff Oncology, Inc.⁷
Sep 16, 2022Bought 30,000 shares at $1.56 of Cardiff Oncology, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKAZIA THERAPEUTICS LTD, Chief financial officer
2
SEC EDGARCardiff Oncology, Inc., Chief financial officer
3
SEC EDGARCidara Therapeutics, Chief financial officer
4
SEC EDGARVerenium Corporation, President
5
SEC EDGARVerenium Corporation, Board member
6
SEC EDGARVerenium Corporation, Chief financial officer
7
SEC EDGARCardiff Oncology, Inc. shares after the filing of Dec 18, 2024
8
SEC EDGARForm 4 filed Sep 19, 2022